Skip to main content

Financial News

  • Endo Health Solutions to buy Paladin Labs

    MALVERN, Pa. — Endo Health Solutions will acquire Canadian drug maker Paladin Labs for $1.6 billion, mostly in shares of stock, Endo said Tuesday.

  • Walgreens generates October sales of $6.4 billion with a 5.8% same-store sales lift

    DEERFIELD, Ill. — Walgreens on Tuesday posted October sales of $6.4 billion, an increase of 6.1%. Sales in comparable stores increased by 5.8% in October. 

    Prescriptions filled at comparable stores increased by 5.7% in October and increased 6.2% on a calendar day-shift adjusted basis. This year’s October had one additional Thursday and one fewer Monday compared with October 2012. These calendar shifts negatively impacted prescriptions filled at comparable stores by 50 basis points.

  • Safeway completes sale of Canadian operations to Sobeys

    PLEASANTON, Calif. — Safeway on Monday announced that it has completed the sale of the net assets of Canada Safeway to Sobeys, a wholly-owned subsidiary of Empire Co.

    Proceeds from the transaction of $3.8 billion in cash after taxes and expenses and between $400 and $450 million in U.S. tax benefits related to the exit of the Chicago market will be used to pay down $2 billion of debt, with the majority of the remainder to be used to buy back stock. In addition, some of the proceeds may be used to invest in growth opportunities, Safeway reported.

  • Publix posts third-quarter comp lift of 4.1%

    LAKELAND, Fla. — Publix on Friday posted sales for third quarter 2013 of $7 billion, representing a 5.6% increase. Comparable-store sales for third quarter 2013 increased 4.1%. 

    Publix's sales for the first nine months of 2013 were $21.6 billion, a 5.2% increase from last year's $20.5 billion. Comparable-store sales for the first nine months of 2013 increased 3.4%. 

  • Carex Health acquires the ThermiPaq Hot & Cold Therapy brand

    NORWELL, Mass. — Carex Health Brands announced the acquisition of the ThermiPaq Hot & Cold Therapy brand along with other associated assets from Thermionics Corp.

  • Dr. Reddy's sales increase by 17%

    HYDERABAD, India — Indian drug maker Dr. Reddy's Labs had sales of $536 million in second-quarter 2014 and profits of $110 million, the company said.

    Those figures represented sales growth of 17% and a 76% growth in profits over second quarter 2013. Seventy-nine percent of the company's sales came from generic drugs, including 50% from sales in North America; sales of generics grew by 32% over last year.

  • Teva sales increase by 2%

    JERUSALEM — Teva Pharmaceutical Industries had $5.1 billion in sales and $711 million in profits in third-quarter 2013, the Israeli drug maker said.

  • Rite Aid comps increase in October

    CAMP HILL, Pa. — Rite Aid's same-store sales increased by 2.1% this month compared with October 2012, the retail pharmacy chain said Thursday, also issuing an estimate of the negative effects of Hurricane Sandy on its sales.

X
This ad will auto-close in 10 seconds